
### [NCIT:C94759](http://purl.obolibrary.org/obo/NCIT_C94759)
**Label:** Functioning Endocrine Neoplasm

**Subclasses:** [NCIT:C67369](http://purl.obolibrary.org/obo/NCIT_C67369) (Malignant Pancreatic Somatostatinoma), [NCIT:C27466](http://purl.obolibrary.org/obo/NCIT_C27466) (Pancreatic ACTH-Producing Neuroendocrine Tumor), [NCIT:C121720](http://purl.obolibrary.org/obo/NCIT_C121720) (Functioning Pituitary Gland Macroadenoma), [NCIT:C65187](http://purl.obolibrary.org/obo/NCIT_C65187) (Malignant Pancreatic Glucagonoma), [NCIT:C7047](http://purl.obolibrary.org/obo/NCIT_C7047) (Functioning Pituitary Gland Neoplasm), [NCIT:C95597](http://purl.obolibrary.org/obo/NCIT_C95597) (Pancreatic Glucagonoma), [NCIT:C8388](http://purl.obolibrary.org/obo/NCIT_C8388) (Functioning Pituitary Gland Adenoma), [NCIT:C121679](http://purl.obolibrary.org/obo/NCIT_C121679) (Functioning Pituitary Gland Microadenoma), [NCIT:C45841](http://purl.obolibrary.org/obo/NCIT_C45841) (Functional Pancreatic Neuroendocrine Tumor G2), [NCIT:C95595](http://purl.obolibrary.org/obo/NCIT_C95595) (Pancreatic Somatostatinoma), [NCIT:C45840](http://purl.obolibrary.org/obo/NCIT_C45840) (Functional Pancreatic Neuroendocrine Tumor), 

**Class expressions from DL-Learner:**

- [NCIT:C45981](http://purl.obolibrary.org/obo/NCIT_C45981) (Presence of a Hormonal Syndrome) 57.14%
- Thing 52.12%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38661](http://purl.obolibrary.org/obo/NCIT_C38661) (Composite Lymphoma))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38660](http://purl.obolibrary.org/obo/NCIT_C38660) (Neoplastic Large B-Lymphocyte with Pale Cytoplasm))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C3866](http://purl.obolibrary.org/obo/NCIT_C3866) (Esophageal Leiomyoma))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38658](http://purl.obolibrary.org/obo/NCIT_C38658) (Transformed Peripheral B-Lymphocyte))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38657](http://purl.obolibrary.org/obo/NCIT_C38657) (Neoplastic Immunoblast-Like B-Lymphocyte))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38656](http://purl.obolibrary.org/obo/NCIT_C38656) (ALK Kinase Overexpression))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38655](http://purl.obolibrary.org/obo/NCIT_C38655) (Bulky Disease))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38650](http://purl.obolibrary.org/obo/NCIT_C38650) (Defective Mu Heavy Chain Present))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38649](http://purl.obolibrary.org/obo/NCIT_C38649) (Vacuolated Plasma Cells in the Bone Marrow))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38648](http://purl.obolibrary.org/obo/NCIT_C38648) (Negative Bone Marrow and Peripheral Blood))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38647](http://purl.obolibrary.org/obo/NCIT_C38647) (Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38646](http://purl.obolibrary.org/obo/NCIT_C38646) (Fried-Egg Appearance of the Bone Marrow))) 42.50%


